Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Vaccinex, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −6 vs. Q4 2023
- Shares held
- 322.6K
- −1.28M (−79.9%) vs. Q4 2023
- Total value
- $2.39M
- +$1.32M (+124.2%) vs. Q4 2023
- New holders
- 4
- 1 more added
- Sold out
- 10
- 7 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $45 |
| Q3 2024 | 12 | $1.14M |
| Q2 2024 | 11 | $1.81M |
| Q1 2024 | 12 | $2.39M |
| Q4 2023 | 18 | $1.07M |
| Q3 2023 | 19 | $2.92M |
| Q2 2023 | 23 | $994.8K |
| Q1 2023 | 24 | $1.10M |
| Q4 2022 | 25 | $3.12M |
| Q3 2022 | 22 | $2.28M |
| Q2 2022 | 27 | $5.03M |
| Q1 2022 | 25 | $5.49M |
| Q4 2021 | 21 | $1.66M |
| Q3 2021 | 23 | $3.36M |
| Q2 2021 | 28 | $4.54M |
| Q1 2021 | 33 | $2.79M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Vaccinex, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 145,000 | $1.07M | 0.03% | +145,000 | New |
| Point72 Asset Management, L.P. | 116,546 | $863.6K | 0.00% | +116,546 | New |
| AIGH Capital Management LLC | 58,365 | $432.5K | 0.21% | −758,696−92.9% | Reduced |
| Morgan Stanley | 1,113 | $8.25K | 0.00% | +1,093+5,465.0% | Added |
| Tower Research Capital LLC (TRC) | 1,045 | $7.74K | 0.00% | −5,611−84.3% | Reduced |
| Tacita Capital Inc | 228 | $1.69K | 0.00% | +228 | New |
| UBS Group AG | 101 | $748 | 0.00% | −238−70.2% | Reduced |
| Group One Trading, L.P. | 67 | $496 | 0.00% | −849−92.7% | Reduced |
| Advisor Group Holdings, Inc. | 53 | $392 | 0.00% | −181−77.4% | Reduced |
| Wells Fargo & Company | 8 | $59 | 0.00% | −60−88.2% | Reduced |
| Royal Bank of Canada | 39 | $0 | 0.00% | −255−86.7% | Reduced |
| Capital Advisors, Ltd. LLC | 13 | $0 | 0.00% | +13 | New |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −654,079−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −48,221−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −32,100−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,159−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −16,100−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,737−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Financial Connections Group, Inc. | 0 | $0 | 0.00% | −270−100.0% | Sold out |